Skip to content

DE · SAE.DE · MEDICAL - PHARMACEUTICALS

Shop Apotheke Europe N.V. (SAE.DE) intrinsic value and stock valuation

$88.30as of 2026-11-21 · Mkt cap 1.61B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Shop Apotheke Europe N.V. DCF and intrinsic value

InvestorsCraft values SAE.DE with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SAE.DE’s statements →

Shop Apotheke Europe N.V. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Pharmaceuticals Sevenum 5975 WD shop-apotheke-europe.com

How the business is doing

Fiscal 2013–2022, USD

Revenue
$1.2B+33.5% 5y CAGRd
20132022
Net income
-$-77.65M
20132022
Free cash flow
-$-82.64M
20132022
Total equity
$354.6M
20132022

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2013–2022, USD
20222021202020192018
Revenue$1.2B$1.06B$968.1M$701M$539.7M
Operating income-$-69.32M-$-43.41M-$-5.12M-$-34.18M-$-28.73M
Net income-$-77.65M-$-74.19M-$-16.77M-$-36.27M-$-33.61M
EPSd-$-4.32M-$-4.15M-$-1.17M-$-2.78M-$-2.79M
Operating cash flow-$-29.11M$11.6M$17.8M-$-30.37M-$-23.54M
Capital expenditure-$-53.52M-$-43.16M-$-53.34M-$-14.74M-$-11.86M
Free cash flow-$-82.64M-$-31.52M-$-35.53M-$-45.11M-$-35.4M
Total assets$729.5M$783.1M$536.9M$428M$350.9M
Total debt$255.2M$236.4M$38.2M$149.2M$88.7M
Net debt$188.8M-$-10.61M-$-51.88M$86.6M$64.4M
Total equity$354.6M$415.4M$425.1M$232.8M$214M
Cash and short-term investments$184M$283.5M$127.9M$113.2M$58.8M
Income statement
20222021202020192018
Revenue$1.2B$1.06B$968.1M$701M$539.7M
Cost of revenue$872.6M$793.8M$748.5M$563.3M$440.4M
Gross profit$331.8M$266.5M$219.5M$137.7M$99.3M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$244.2M$196.9M$145.2M$108.7M$81.4M
Other expenses$156.9M$113.1M$75.2M$63.2M$46.6M
Operating expenses$401.1M$309.9M$220.5M$171.9M$128.1M
Cost and expenses$1.27B$1.1B$969M$735.2M$568.4M
Interest income$270K$30K$90K$110K$320K
Interest expense$8.5M$8.57M$10.4M$7.48M$6.18M
Depreciation and amortization$36.1M$23.5M$16.1M$13.8M$13.2M
Ebitda-$-39.53M-$-45.82M$10.6M-$-20.95M-$-15.23M
Operating income-$-69.32M-$-43.41M-$-5.12M-$-34.18M-$-28.73M
Total other income/expenses, net-$-14.8M-$-34.48M-$-10.81M-$-8M-$-5.86M
Income before tax-$-84.12M-$-77.88M-$-15.93M-$-42.18M-$-34.59M
Income tax expense-$-6.47M-$-3.7M$840K-$-5.91M-$-980K
Net income-$-77.65M-$-74.19M-$-16.77M-$-36.27M-$-33.61M
Weighted average shares outstanding$18M$17.9M$14.4M$13.1M$12.1M
Weighted average diluted shares outstanding$18M$17.9M$14.4M$13.1M$12.1M
Balance sheet
20222021202020192018
Cash and short-term investments$184M$283.5M$127.9M$113.2M$58.8M
Net receivables$47.9M$40.2M$35.1M$32.4M$0.00
Inventory$99.7M$96.6M$81.2M$56.7M$43.4M
Total current assets$343.9M$432.8M$254.1M$210.8M$136.7M
Property, plant and equipment, net$85.4M$78.3M$74.6M$13.2M$11.9M
Goodwill and intangible assets$289M$257.5M$204.7M$199.9M$192.6M
Long-term investments-$-106.9M-$-21.84M-$-34.27M-$-46.56M-$-33.01M
Total non-current assets$385.6M$350.3M$282.8M$217.2M$214.2M
Total assets$729.5M$783.1M$536.9M$428M$350.9M
Accounts payable$68.9M$78.1M$51.3M$31.4M$26.1M
Short-term debt$7.54M$6.41M$5.42M$17.7M$16.3M
Deferred revenue$0.00$32.9M$13.1M$7.54M$0.00
Total current liabilities$119.3M$124.1M$74.6M$59.8M$53.7M
Long-term debt$247.7M$230M$32.8M$131.5M$72.4M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$255.5M$243.6M$37.2M$135.4M$83.3M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$374.8M$367.7M$111.8M$195.2M$136.9M
Common stock$360K$360K$350K$270K$292.1M
Retained earnings-$-285.43M$0.00$0.00$0.00$0.00
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00-$-5.88M
Total equity$354.6M$415.4M$425.1M$232.8M$214M
Total investments$10.7M$14.6M$3.5M$4.02M$1.41M
Total debt$255.2M$236.4M$38.2M$149.2M$88.7M
Net debt$188.8M-$-10.61M-$-51.88M$86.6M$64.4M
Cash flow statement
20222021202020192018
Net income-$-69.17M-$-65.7M-$-870K-$-33.45M-$-33.61M
Depreciation and amortization$39.5M$27M$16.1M$14.9M$13.2M
Stock-based compensation$16.2M$20.5M$4.41M$2.97M$1.45M
Change in working capital-$-16.98M$28.5M-$-1.24M-$-14.73M-$-9.43M
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory-$-3.08M-$-15.38M-$-24.55M-$-13.34M$130K
Accounts payable$0.00$0.00$0.00$0.00$0.00
Net cash provided by operating activities-$-29.11M$11.6M$17.8M-$-30.37M-$-23.54M
Investments in property, plant and equipment-$-53.52M-$-43.16M-$-53.34M-$-14.74M-$-11.86M
Acquisitions, net-$-6.02M-$-31.18M$0.00$0.00$0.00
Net cash used for investing activities-$-138.01M-$-84.3M-$-40.26M-$-33.4M-$-38.15M
Common stock issued$640K$12.2M$75.7M$49.2M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-13.52M$229.6M$50.3M$102.1M$65.3M
Net change in cash-$-180.64M$156.9M$27.8M$38.3M$3.61M
Cash at end of period$66.8M$247.4M$90.5M$62.7M$14.5M
Operating cash flow-$-29.11M$11.6M$17.8M-$-30.37M-$-23.54M
Capital expenditure-$-53.52M-$-43.16M-$-53.34M-$-14.74M-$-11.86M
Free cash flow-$-82.64M-$-31.52M-$-35.53M-$-45.11M-$-35.4M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Shop Apotheke Europe N.V.

        Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

        CEO
        Stephan Weber
        Employees
        1.64K
        Beta
        0.88

        Explore

        Frequently asked questions

        What is the intrinsic value of Shop Apotheke Europe N.V. (SAE.DE)?

        InvestorsCraft does not currently publish an intrinsic value for SAE.DE. How the IC value is calculated.

        Is SAE.DE undervalued?

        InvestorsCraft does not publish an undervaluation signal for SAE.DE at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.